nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—CXCL8—malignant glioma	0.286	0.401	CbGaD
Indomethacin—PPARG—malignant glioma	0.198	0.277	CbGaD
Indomethacin—PTGS1—malignant glioma	0.146	0.205	CbGaD
Indomethacin—PTGS2—malignant glioma	0.0834	0.117	CbGaD
Indomethacin—SLC22A8—choroid plexus—malignant glioma	0.00831	0.113	CbGeAlD
Indomethacin—Lung infection—Temozolomide—malignant glioma	0.00593	0.0812	CcSEcCtD
Indomethacin—PTGR2—embryo—malignant glioma	0.0027	0.0369	CbGeAlD
Indomethacin—ABCC11—embryo—malignant glioma	0.00268	0.0365	CbGeAlD
Indomethacin—PPARA—blood vessel—malignant glioma	0.00243	0.0331	CbGeAlD
Indomethacin—Haemorrhage intracranial—Temozolomide—malignant glioma	0.00237	0.0325	CcSEcCtD
Indomethacin—Azotaemia—Carmustine—malignant glioma	0.00189	0.0259	CcSEcCtD
Indomethacin—PTGDR2—cerebellum—malignant glioma	0.00184	0.0251	CbGeAlD
Indomethacin—PTGR2—medulla oblongata—malignant glioma	0.00173	0.0236	CbGeAlD
Indomethacin—PTGR2—midbrain—malignant glioma	0.00158	0.0215	CbGeAlD
Indomethacin—PTGR2—spinal cord—malignant glioma	0.00154	0.021	CbGeAlD
Indomethacin—PTGDR2—brain—malignant glioma	0.0015	0.0204	CbGeAlD
Indomethacin—GLO1—retina—malignant glioma	0.00148	0.0201	CbGeAlD
Indomethacin—PPARA—embryo—malignant glioma	0.00145	0.0198	CbGeAlD
Indomethacin—PPARG—endothelium—malignant glioma	0.00145	0.0198	CbGeAlD
Indomethacin—Apathy—Temozolomide—malignant glioma	0.00136	0.0187	CcSEcCtD
Indomethacin—ABCC6—retina—malignant glioma	0.00136	0.0185	CbGeAlD
Indomethacin—GLO1—telencephalon—malignant glioma	0.00136	0.0185	CbGeAlD
Indomethacin—Flat affect—Temozolomide—malignant glioma	0.00135	0.0185	CcSEcCtD
Indomethacin—PPARG—blood vessel—malignant glioma	0.00134	0.0182	CbGeAlD
Indomethacin—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00132	0.018	CcSEcCtD
Indomethacin—PPARA—retina—malignant glioma	0.00128	0.0175	CbGeAlD
Indomethacin—PLA2G2A—telencephalon—malignant glioma	0.00126	0.0172	CbGeAlD
Indomethacin—Coagulopathy—Temozolomide—malignant glioma	0.00125	0.0171	CcSEcCtD
Indomethacin—PTGR2—central nervous system—malignant glioma	0.00125	0.017	CbGeAlD
Indomethacin—Tolmetin—CXCL8—malignant glioma	0.00124	0.24	CrCbGaD
Indomethacin—PTGR2—cerebellum—malignant glioma	0.00122	0.0167	CbGeAlD
Indomethacin—Petechiae—Temozolomide—malignant glioma	0.00118	0.0162	CcSEcCtD
Indomethacin—GLO1—medulla oblongata—malignant glioma	0.00107	0.0146	CbGeAlD
Indomethacin—PTGR2—brain—malignant glioma	0.000992	0.0135	CbGeAlD
Indomethacin—CXCL8—medulla oblongata—malignant glioma	0.000982	0.0134	CbGeAlD
Indomethacin—GLO1—midbrain—malignant glioma	0.000976	0.0133	CbGeAlD
Indomethacin—Skin exfoliation—Carmustine—malignant glioma	0.000962	0.0132	CcSEcCtD
Indomethacin—GLO1—spinal cord—malignant glioma	0.000952	0.013	CbGeAlD
Indomethacin—Bromfenac—PTGS1—malignant glioma	0.00094	0.182	CrCbGaD
Indomethacin—Skin exfoliation—Temozolomide—malignant glioma	0.00093	0.0127	CcSEcCtD
Indomethacin—Coma—Carmustine—malignant glioma	0.000921	0.0126	CcSEcCtD
Indomethacin—Aplastic anaemia—Temozolomide—malignant glioma	0.000915	0.0125	CcSEcCtD
Indomethacin—PLA2G2A—midbrain—malignant glioma	0.000907	0.0124	CbGeAlD
Indomethacin—Gynaecomastia—Carmustine—malignant glioma	0.000902	0.0123	CcSEcCtD
Indomethacin—CXCL8—midbrain—malignant glioma	0.000898	0.0122	CbGeAlD
Indomethacin—CXCL8—spinal cord—malignant glioma	0.000876	0.0119	CbGeAlD
Indomethacin—Thrombophlebitis—Carmustine—malignant glioma	0.000845	0.0116	CcSEcCtD
Indomethacin—Thrombophlebitis—Temozolomide—malignant glioma	0.000817	0.0112	CcSEcCtD
Indomethacin—Eye pain—Carmustine—malignant glioma	0.00081	0.0111	CcSEcCtD
Indomethacin—Gastroenteritis—Temozolomide—malignant glioma	0.000798	0.0109	CcSEcCtD
Indomethacin—PPARG—embryo—malignant glioma	0.000798	0.0109	CbGeAlD
Indomethacin—Deafness—Temozolomide—malignant glioma	0.00079	0.0108	CcSEcCtD
Indomethacin—Vascular purpura—Temozolomide—malignant glioma	0.00079	0.0108	CcSEcCtD
Indomethacin—Eye pain—Temozolomide—malignant glioma	0.000783	0.0107	CcSEcCtD
Indomethacin—PTGS1—endothelium—malignant glioma	0.000775	0.0106	CbGeAlD
Indomethacin—GLO1—central nervous system—malignant glioma	0.000772	0.0105	CbGeAlD
Indomethacin—AKR1C3—medulla oblongata—malignant glioma	0.00077	0.0105	CbGeAlD
Indomethacin—Hot flush—Temozolomide—malignant glioma	0.000756	0.0103	CcSEcCtD
Indomethacin—GLO1—cerebellum—malignant glioma	0.000755	0.0103	CbGeAlD
Indomethacin—Menopausal symptoms—Temozolomide—malignant glioma	0.000749	0.0103	CcSEcCtD
Indomethacin—Dermatitis exfoliative—Temozolomide—malignant glioma	0.000749	0.0103	CcSEcCtD
Indomethacin—PTGS2—endothelium—malignant glioma	0.000741	0.0101	CbGeAlD
Indomethacin—Hyponatraemia—Carmustine—malignant glioma	0.000735	0.0101	CcSEcCtD
Indomethacin—Purpura—Temozolomide—malignant glioma	0.000734	0.01	CcSEcCtD
Indomethacin—Diplopia—Carmustine—malignant glioma	0.000732	0.01	CcSEcCtD
Indomethacin—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000732	0.01	CcSEcCtD
Indomethacin—PLA2G2A—central nervous system—malignant glioma	0.000718	0.00979	CbGeAlD
Indomethacin—PTGS1—blood vessel—malignant glioma	0.000715	0.00974	CbGeAlD
Indomethacin—Diplopia—Temozolomide—malignant glioma	0.000707	0.00968	CcSEcCtD
Indomethacin—AKR1C3—midbrain—malignant glioma	0.000704	0.00959	CbGeAlD
Indomethacin—Bezafibrate—PPARG—malignant glioma	0.000704	0.136	CrCbGaD
Indomethacin—CXCL8—cerebellum—malignant glioma	0.000695	0.00947	CbGeAlD
Indomethacin—AKR1C3—spinal cord—malignant glioma	0.000687	0.00936	CbGeAlD
Indomethacin—PTGS2—blood vessel—malignant glioma	0.000683	0.00931	CbGeAlD
Indomethacin—PPARA—central nervous system—malignant glioma	0.000671	0.00914	CbGeAlD
Indomethacin—PPARA—cerebellum—malignant glioma	0.000655	0.00893	CbGeAlD
Indomethacin—Muscular weakness—Carmustine—malignant glioma	0.000645	0.00883	CcSEcCtD
Indomethacin—SLC10A1—central nervous system—malignant glioma	0.000645	0.00879	CbGeAlD
Indomethacin—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000637	0.00872	CcSEcCtD
Indomethacin—Tolmetin—PTGS1—malignant glioma	0.000632	0.122	CrCbGaD
Indomethacin—Muscular weakness—Temozolomide—malignant glioma	0.000624	0.00854	CcSEcCtD
Indomethacin—Abdominal distension—Temozolomide—malignant glioma	0.000615	0.00842	CcSEcCtD
Indomethacin—GLO1—brain—malignant glioma	0.000613	0.00836	CbGeAlD
Indomethacin—SLCO1A2—telencephalon—malignant glioma	0.000612	0.00834	CbGeAlD
Indomethacin—Pancytopenia—Carmustine—malignant glioma	0.000601	0.00822	CcSEcCtD
Indomethacin—Pancytopenia—Temozolomide—malignant glioma	0.00058	0.00794	CcSEcCtD
Indomethacin—Hyperglycaemia—Carmustine—malignant glioma	0.00057	0.00781	CcSEcCtD
Indomethacin—PLA2G2A—brain—malignant glioma	0.00057	0.00777	CbGeAlD
Indomethacin—Pollakiuria—Temozolomide—malignant glioma	0.000565	0.00773	CcSEcCtD
Indomethacin—CXCL8—brain—malignant glioma	0.000564	0.00769	CbGeAlD
Indomethacin—Depression—Carmustine—malignant glioma	0.000562	0.0077	CcSEcCtD
Indomethacin—Weight increased—Temozolomide—malignant glioma	0.000556	0.00761	CcSEcCtD
Indomethacin—Renal failure—Carmustine—malignant glioma	0.000554	0.00759	CcSEcCtD
Indomethacin—Neuropathy peripheral—Carmustine—malignant glioma	0.000553	0.00757	CcSEcCtD
Indomethacin—Hyperglycaemia—Temozolomide—malignant glioma	0.000551	0.00755	CcSEcCtD
Indomethacin—Stomatitis—Carmustine—malignant glioma	0.00055	0.00752	CcSEcCtD
Indomethacin—AKR1C3—cerebellum—malignant glioma	0.000545	0.00742	CbGeAlD
Indomethacin—Depression—Temozolomide—malignant glioma	0.000543	0.00744	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00054	0.0074	CcSEcCtD
Indomethacin—Bromfenac—PTGS2—malignant glioma	0.000537	0.104	CrCbGaD
Indomethacin—Neuropathy peripheral—Temozolomide—malignant glioma	0.000534	0.00731	CcSEcCtD
Indomethacin—PPARA—brain—malignant glioma	0.000532	0.00726	CbGeAlD
Indomethacin—Stomatitis—Temozolomide—malignant glioma	0.000531	0.00727	CcSEcCtD
Indomethacin—SLC10A1—brain—malignant glioma	0.000512	0.00698	CbGeAlD
Indomethacin—Haemoglobin—Carmustine—malignant glioma	0.000509	0.00696	CcSEcCtD
Indomethacin—Haemorrhage—Carmustine—malignant glioma	0.000506	0.00693	CcSEcCtD
Indomethacin—ABCC1—telencephalon—malignant glioma	0.000502	0.00685	CbGeAlD
Indomethacin—CES1—central nervous system—malignant glioma	0.000498	0.00678	CbGeAlD
Indomethacin—Haemoglobin—Temozolomide—malignant glioma	0.000492	0.00673	CcSEcCtD
Indomethacin—Hepatitis—Temozolomide—malignant glioma	0.000489	0.0067	CcSEcCtD
Indomethacin—Haemorrhage—Temozolomide—malignant glioma	0.000489	0.0067	CcSEcCtD
Indomethacin—SLCO1A2—medulla oblongata—malignant glioma	0.000481	0.00656	CbGeAlD
Indomethacin—Naproxen—PTGS1—malignant glioma	0.000475	0.0921	CrCbGaD
Indomethacin—Flushing—Carmustine—malignant glioma	0.00047	0.00643	CcSEcCtD
Indomethacin—Erythema multiforme—Temozolomide—malignant glioma	0.000463	0.00633	CcSEcCtD
Indomethacin—SLC22A7—brain—malignant glioma	0.000456	0.00622	CbGeAlD
Indomethacin—Tinnitus—Temozolomide—malignant glioma	0.000456	0.00624	CcSEcCtD
Indomethacin—Flushing—Temozolomide—malignant glioma	0.000454	0.00621	CcSEcCtD
Indomethacin—Arrhythmia—Carmustine—malignant glioma	0.000452	0.00619	CcSEcCtD
Indomethacin—Alopecia—Carmustine—malignant glioma	0.000447	0.00612	CcSEcCtD
Indomethacin—AKR1C3—brain—malignant glioma	0.000442	0.00603	CbGeAlD
Indomethacin—Erythema—Carmustine—malignant glioma	0.000441	0.00603	CcSEcCtD
Indomethacin—SLC22A6—brain—malignant glioma	0.000441	0.006	CbGeAlD
Indomethacin—SLCO1A2—midbrain—malignant glioma	0.00044	0.00599	CbGeAlD
Indomethacin—Alopecia—Temozolomide—malignant glioma	0.000432	0.00592	CcSEcCtD
Indomethacin—SLCO1A2—spinal cord—malignant glioma	0.000429	0.00585	CbGeAlD
Indomethacin—Erythema—Temozolomide—malignant glioma	0.000426	0.00583	CcSEcCtD
Indomethacin—ABCB1—blood vessel—malignant glioma	0.000423	0.00576	CbGeAlD
Indomethacin—Vision blurred—Carmustine—malignant glioma	0.000415	0.00568	CcSEcCtD
Indomethacin—PTGS2—embryo—malignant glioma	0.000408	0.00556	CbGeAlD
Indomethacin—Anaemia—Carmustine—malignant glioma	0.000407	0.00558	CcSEcCtD
Indomethacin—ABCC3—central nervous system—malignant glioma	0.000406	0.00553	CbGeAlD
Indomethacin—Vision blurred—Temozolomide—malignant glioma	0.000401	0.00549	CcSEcCtD
Indomethacin—Ill-defined disorder—Temozolomide—malignant glioma	0.000395	0.00541	CcSEcCtD
Indomethacin—CES1—brain—malignant glioma	0.000395	0.00538	CbGeAlD
Indomethacin—Leukopenia—Carmustine—malignant glioma	0.000394	0.0054	CcSEcCtD
Indomethacin—Anaemia—Temozolomide—malignant glioma	0.000394	0.00539	CcSEcCtD
Indomethacin—Angioedema—Temozolomide—malignant glioma	0.000389	0.00533	CcSEcCtD
Indomethacin—Malaise—Temozolomide—malignant glioma	0.000384	0.00526	CcSEcCtD
Indomethacin—Vertigo—Temozolomide—malignant glioma	0.000383	0.00524	CcSEcCtD
Indomethacin—Convulsion—Carmustine—malignant glioma	0.000382	0.00523	CcSEcCtD
Indomethacin—Leukopenia—Temozolomide—malignant glioma	0.000381	0.00522	CcSEcCtD
Indomethacin—Hypertension—Carmustine—malignant glioma	0.00038	0.00521	CcSEcCtD
Indomethacin—Palpitations—Temozolomide—malignant glioma	0.000376	0.00515	CcSEcCtD
Indomethacin—Chest pain—Carmustine—malignant glioma	0.000375	0.00514	CcSEcCtD
Indomethacin—Anxiety—Carmustine—malignant glioma	0.000374	0.00512	CcSEcCtD
Indomethacin—Convulsion—Temozolomide—malignant glioma	0.000369	0.00505	CcSEcCtD
Indomethacin—PPARG—central nervous system—malignant glioma	0.000369	0.00503	CbGeAlD
Indomethacin—Hypertension—Temozolomide—malignant glioma	0.000368	0.00503	CcSEcCtD
Indomethacin—Confusional state—Carmustine—malignant glioma	0.000363	0.00496	CcSEcCtD
Indomethacin—Anxiety—Temozolomide—malignant glioma	0.000361	0.00495	CcSEcCtD
Indomethacin—Tolmetin—PTGS2—malignant glioma	0.000361	0.07	CrCbGaD
Indomethacin—Oedema—Carmustine—malignant glioma	0.00036	0.00492	CcSEcCtD
Indomethacin—Discomfort—Temozolomide—malignant glioma	0.000358	0.0049	CcSEcCtD
Indomethacin—Thrombocytopenia—Carmustine—malignant glioma	0.000352	0.00482	CcSEcCtD
Indomethacin—Tachycardia—Carmustine—malignant glioma	0.000351	0.0048	CcSEcCtD
Indomethacin—Confusional state—Temozolomide—malignant glioma	0.00035	0.0048	CcSEcCtD
Indomethacin—SLCO1A2—central nervous system—malignant glioma	0.000348	0.00474	CbGeAlD
Indomethacin—Anaphylactic shock—Temozolomide—malignant glioma	0.000348	0.00476	CcSEcCtD
Indomethacin—Oedema—Temozolomide—malignant glioma	0.000348	0.00476	CcSEcCtD
Indomethacin—PTGS1—telencephalon—malignant glioma	0.000347	0.00473	CbGeAlD
Indomethacin—Anorexia—Carmustine—malignant glioma	0.000343	0.00469	CcSEcCtD
Indomethacin—Thrombocytopenia—Temozolomide—malignant glioma	0.00034	0.00466	CcSEcCtD
Indomethacin—SLCO1A2—cerebellum—malignant glioma	0.00034	0.00464	CbGeAlD
Indomethacin—Hypotension—Carmustine—malignant glioma	0.000336	0.0046	CcSEcCtD
Indomethacin—Hyperhidrosis—Temozolomide—malignant glioma	0.000336	0.0046	CcSEcCtD
Indomethacin—ABCC4—central nervous system—malignant glioma	0.000335	0.00456	CbGeAlD
Indomethacin—SLC22A8—central nervous system—malignant glioma	0.000332	0.00453	CbGeAlD
Indomethacin—PTGS2—telencephalon—malignant glioma	0.000332	0.00452	CbGeAlD
Indomethacin—Anorexia—Temozolomide—malignant glioma	0.000331	0.00453	CcSEcCtD
Indomethacin—Insomnia—Carmustine—malignant glioma	0.000325	0.00445	CcSEcCtD
Indomethacin—Paraesthesia—Carmustine—malignant glioma	0.000323	0.00442	CcSEcCtD
Indomethacin—ABCC3—brain—malignant glioma	0.000322	0.00439	CbGeAlD
Indomethacin—Dyspnoea—Carmustine—malignant glioma	0.000321	0.00439	CcSEcCtD
Indomethacin—Somnolence—Carmustine—malignant glioma	0.00032	0.00438	CcSEcCtD
Indomethacin—Insomnia—Temozolomide—malignant glioma	0.000314	0.0043	CcSEcCtD
Indomethacin—Decreased appetite—Carmustine—malignant glioma	0.000313	0.00428	CcSEcCtD
Indomethacin—Paraesthesia—Temozolomide—malignant glioma	0.000312	0.00427	CcSEcCtD
Indomethacin—Dyspnoea—Temozolomide—malignant glioma	0.00031	0.00424	CcSEcCtD
Indomethacin—Somnolence—Temozolomide—malignant glioma	0.000309	0.00423	CcSEcCtD
Indomethacin—Pain—Carmustine—malignant glioma	0.000308	0.00421	CcSEcCtD
Indomethacin—Constipation—Carmustine—malignant glioma	0.000308	0.00421	CcSEcCtD
Indomethacin—Dyspepsia—Temozolomide—malignant glioma	0.000306	0.00419	CcSEcCtD
Indomethacin—Decreased appetite—Temozolomide—malignant glioma	0.000302	0.00414	CcSEcCtD
Indomethacin—Fatigue—Temozolomide—malignant glioma	0.0003	0.0041	CcSEcCtD
Indomethacin—Pain—Temozolomide—malignant glioma	0.000297	0.00407	CcSEcCtD
Indomethacin—Constipation—Temozolomide—malignant glioma	0.000297	0.00407	CcSEcCtD
Indomethacin—Feeling abnormal—Carmustine—malignant glioma	0.000296	0.00406	CcSEcCtD
Indomethacin—Gastrointestinal pain—Carmustine—malignant glioma	0.000294	0.00403	CcSEcCtD
Indomethacin—PPARG—brain—malignant glioma	0.000293	0.00399	CbGeAlD
Indomethacin—Feeling abnormal—Temozolomide—malignant glioma	0.000286	0.00392	CcSEcCtD
Indomethacin—Abdominal pain—Carmustine—malignant glioma	0.000284	0.00389	CcSEcCtD
Indomethacin—Body temperature increased—Carmustine—malignant glioma	0.000284	0.00389	CcSEcCtD
Indomethacin—Gastrointestinal pain—Temozolomide—malignant glioma	0.000284	0.00389	CcSEcCtD
Indomethacin—ABCC1—cerebellum—malignant glioma	0.000279	0.0038	CbGeAlD
Indomethacin—SLCO1A2—brain—malignant glioma	0.000276	0.00377	CbGeAlD
Indomethacin—Urticaria—Temozolomide—malignant glioma	0.000276	0.00378	CcSEcCtD
Indomethacin—Abdominal pain—Temozolomide—malignant glioma	0.000275	0.00376	CcSEcCtD
Indomethacin—Body temperature increased—Temozolomide—malignant glioma	0.000275	0.00376	CcSEcCtD
Indomethacin—ALB—brain—malignant glioma	0.000275	0.00374	CbGeAlD
Indomethacin—Naproxen—PTGS2—malignant glioma	0.000272	0.0527	CrCbGaD
Indomethacin—ABCC4—brain—malignant glioma	0.000266	0.00362	CbGeAlD
Indomethacin—Hypersensitivity—Carmustine—malignant glioma	0.000265	0.00363	CcSEcCtD
Indomethacin—SLC22A8—brain—malignant glioma	0.000264	0.00359	CbGeAlD
Indomethacin—PTGS2—medulla oblongata—malignant glioma	0.00026	0.00355	CbGeAlD
Indomethacin—Asthenia—Carmustine—malignant glioma	0.000258	0.00353	CcSEcCtD
Indomethacin—Hypersensitivity—Temozolomide—malignant glioma	0.000256	0.00351	CcSEcCtD
Indomethacin—ABCB1—embryo—malignant glioma	0.000252	0.00344	CbGeAlD
Indomethacin—Asthenia—Temozolomide—malignant glioma	0.000249	0.00341	CcSEcCtD
Indomethacin—Diarrhoea—Carmustine—malignant glioma	0.000246	0.00337	CcSEcCtD
Indomethacin—Pruritus—Temozolomide—malignant glioma	0.000246	0.00337	CcSEcCtD
Indomethacin—PTGS1—spinal cord—malignant glioma	0.000243	0.00331	CbGeAlD
Indomethacin—PTGS2—midbrain—malignant glioma	0.000238	0.00324	CbGeAlD
Indomethacin—Dizziness—Carmustine—malignant glioma	0.000238	0.00326	CcSEcCtD
Indomethacin—Diarrhoea—Temozolomide—malignant glioma	0.000238	0.00326	CcSEcCtD
Indomethacin—PTGS2—spinal cord—malignant glioma	0.000232	0.00317	CbGeAlD
Indomethacin—Dizziness—Temozolomide—malignant glioma	0.00023	0.00315	CcSEcCtD
Indomethacin—Vomiting—Carmustine—malignant glioma	0.000229	0.00313	CcSEcCtD
Indomethacin—Rash—Carmustine—malignant glioma	0.000227	0.0031	CcSEcCtD
Indomethacin—ABCC1—brain—malignant glioma	0.000227	0.00309	CbGeAlD
Indomethacin—Dermatitis—Carmustine—malignant glioma	0.000227	0.0031	CcSEcCtD
Indomethacin—Headache—Carmustine—malignant glioma	0.000225	0.00308	CcSEcCtD
Indomethacin—ABCB1—retina—malignant glioma	0.000223	0.00304	CbGeAlD
Indomethacin—Vomiting—Temozolomide—malignant glioma	0.000221	0.00302	CcSEcCtD
Indomethacin—Rash—Temozolomide—malignant glioma	0.000219	0.003	CcSEcCtD
Indomethacin—Dermatitis—Temozolomide—malignant glioma	0.000219	0.003	CcSEcCtD
Indomethacin—Headache—Temozolomide—malignant glioma	0.000218	0.00298	CcSEcCtD
Indomethacin—Nausea—Carmustine—malignant glioma	0.000214	0.00292	CcSEcCtD
Indomethacin—Nausea—Temozolomide—malignant glioma	0.000206	0.00283	CcSEcCtD
Indomethacin—ABCB1—telencephalon—malignant glioma	0.000205	0.0028	CbGeAlD
Indomethacin—PTGS1—central nervous system—malignant glioma	0.000197	0.00269	CbGeAlD
Indomethacin—PTGS2—central nervous system—malignant glioma	0.000188	0.00257	CbGeAlD
Indomethacin—PTGS2—cerebellum—malignant glioma	0.000184	0.00251	CbGeAlD
Indomethacin—ABCB1—medulla oblongata—malignant glioma	0.000161	0.0022	CbGeAlD
Indomethacin—PTGS1—brain—malignant glioma	0.000157	0.00213	CbGeAlD
Indomethacin—PTGS2—brain—malignant glioma	0.00015	0.00204	CbGeAlD
Indomethacin—ABCB1—midbrain—malignant glioma	0.000147	0.00201	CbGeAlD
Indomethacin—ABCB1—spinal cord—malignant glioma	0.000144	0.00196	CbGeAlD
Indomethacin—ABCB1—central nervous system—malignant glioma	0.000117	0.00159	CbGeAlD
Indomethacin—ABCB1—cerebellum—malignant glioma	0.000114	0.00155	CbGeAlD
Indomethacin—ABCB1—brain—malignant glioma	9.25e-05	0.00126	CbGeAlD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	6.59e-06	4.88e-05	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—PIK3CA—malignant glioma	6.58e-06	4.87e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—RAF1—malignant glioma	6.55e-06	4.85e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PIK3CD—malignant glioma	6.55e-06	4.85e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.54e-06	4.84e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—CAV1—malignant glioma	6.51e-06	4.82e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CG—malignant glioma	6.47e-06	4.79e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CG—malignant glioma	6.47e-06	4.79e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PDGFRA—malignant glioma	6.44e-06	4.77e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GSTT1—malignant glioma	6.43e-06	4.76e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—PIK3CB—malignant glioma	6.4e-06	4.74e-05	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—AKT1—malignant glioma	6.32e-06	4.68e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—PIK3CA—malignant glioma	6.32e-06	4.68e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MDM2—malignant glioma	6.29e-06	4.66e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GSTT1—malignant glioma	6.27e-06	4.64e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—RAF1—malignant glioma	6.27e-06	4.64e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—FGF2—malignant glioma	6.27e-06	4.64e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PPARG—malignant glioma	6.24e-06	4.62e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PPARG—malignant glioma	6.24e-06	4.62e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—BCHE—malignant glioma	6.24e-06	4.62e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CG—malignant glioma	6.24e-06	4.62e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	6.22e-06	4.61e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.22e-06	4.61e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.22e-06	4.6e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—ERBB2—malignant glioma	6.2e-06	4.59e-05	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	6.18e-06	4.58e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—SLC5A5—malignant glioma	6.16e-06	4.56e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GSTP1—malignant glioma	6.13e-06	4.54e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PIK3CB—malignant glioma	6.12e-06	4.53e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PIK3CB—malignant glioma	6.1e-06	4.51e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PIK3CB—malignant glioma	6.1e-06	4.51e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PIK3CD—malignant glioma	6.09e-06	4.51e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	6.09e-06	4.51e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—VEGFA—malignant glioma	6.06e-06	4.48e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PTGS2—malignant glioma	6.04e-06	4.47e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PTGS2—malignant glioma	6.04e-06	4.47e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTGS1—malignant glioma	6.02e-06	4.46e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PPARG—malignant glioma	6.02e-06	4.45e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	6.01e-06	4.45e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6e-06	4.44e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—STAT3—malignant glioma	6e-06	4.44e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CAT—malignant glioma	5.97e-06	4.42e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TERT—malignant glioma	5.93e-06	4.39e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—HLA-A—malignant glioma	5.93e-06	4.39e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CG—malignant glioma	5.93e-06	4.39e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTGS1—malignant glioma	5.88e-06	4.35e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—IL2—malignant glioma	5.88e-06	4.35e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MDM2—malignant glioma	5.86e-06	4.34e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GSTT1—malignant glioma	5.86e-06	4.34e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—RAF1—malignant glioma	5.84e-06	4.33e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.83e-06	4.31e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PDGFB—malignant glioma	5.79e-06	4.29e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CAV1—malignant glioma	5.79e-06	4.28e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—ERBB2—malignant glioma	5.78e-06	4.28e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.77e-06	4.27e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PIK3CB—malignant glioma	5.77e-06	4.27e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—FGFR1—malignant glioma	5.76e-06	4.26e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PPARG—malignant glioma	5.72e-06	4.23e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTGS2—malignant glioma	5.71e-06	4.23e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PIK3CB—malignant glioma	5.7e-06	4.22e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CD—malignant glioma	5.68e-06	4.21e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CD—malignant glioma	5.68e-06	4.21e-05	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—AKT1—malignant glioma	5.68e-06	4.21e-05	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	5.67e-06	4.2e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—HIF1A—malignant glioma	5.67e-06	4.2e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—PIK3CA—malignant glioma	5.66e-06	4.19e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTGS2—malignant glioma	5.65e-06	4.18e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—NCOR1—malignant glioma	5.64e-06	4.17e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CASP3—malignant glioma	5.63e-06	4.17e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL2—malignant glioma	5.62e-06	4.16e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—BCHE—malignant glioma	5.6e-06	4.14e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MYC—malignant glioma	5.57e-06	4.12e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—SLC5A5—malignant glioma	5.53e-06	4.09e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.53e-06	4.09e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—AKT1—malignant glioma	5.52e-06	4.08e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTGS1—malignant glioma	5.49e-06	4.06e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CAV1—malignant glioma	5.49e-06	4.06e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CD—malignant glioma	5.48e-06	4.06e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	5.47e-06	4.05e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—BCHE—malignant glioma	5.46e-06	4.04e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—EGFR—malignant glioma	5.45e-06	4.03e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—SLC5A5—malignant glioma	5.4e-06	4e-05	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—AKT1—malignant glioma	5.37e-06	3.98e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—MYC—malignant glioma	5.33e-06	3.94e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MMP9—malignant glioma	5.32e-06	3.94e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PIK3CB—malignant glioma	5.31e-06	3.93e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PTEN—malignant glioma	5.29e-06	3.92e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CG—malignant glioma	5.27e-06	3.9e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PTEN—malignant glioma	5.27e-06	3.9e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PTEN—malignant glioma	5.27e-06	3.9e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTGS2—malignant glioma	5.26e-06	3.89e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.23e-06	3.87e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CD—malignant glioma	5.21e-06	3.86e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.18e-06	3.84e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—AKT1—malignant glioma	5.16e-06	3.82e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—BAD—malignant glioma	5.16e-06	3.82e-05	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—AKT1—malignant glioma	5.15e-06	3.81e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—KRAS—malignant glioma	5.15e-06	3.81e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NOTCH1—malignant glioma	5.11e-06	3.78e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—BCHE—malignant glioma	5.1e-06	3.78e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PPARG—malignant glioma	5.09e-06	3.77e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SLC5A5—malignant glioma	5.04e-06	3.73e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.03e-06	3.73e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CD80—malignant glioma	5.01e-06	3.71e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—APC—malignant glioma	5e-06	3.7e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—VEGFA—malignant glioma	4.99e-06	3.7e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTEN—malignant glioma	4.98e-06	3.69e-05	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	4.97e-06	3.68e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GSTP1—malignant glioma	4.96e-06	3.67e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CB—malignant glioma	4.95e-06	3.67e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CB—malignant glioma	4.95e-06	3.67e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—EGF—malignant glioma	4.94e-06	3.66e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTEN—malignant glioma	4.93e-06	3.65e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTGS2—malignant glioma	4.91e-06	3.63e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTGS2—malignant glioma	4.91e-06	3.63e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PTPN11—malignant glioma	4.91e-06	3.63e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PIK3CA—malignant glioma	4.9e-06	3.63e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CAT—malignant glioma	4.83e-06	3.57e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CB—malignant glioma	4.78e-06	3.54e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—VEGFA—malignant glioma	4.78e-06	3.54e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.77e-06	3.53e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTGS2—malignant glioma	4.73e-06	3.5e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—STAT3—malignant glioma	4.73e-06	3.5e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PIK3CA—malignant glioma	4.73e-06	3.5e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.72e-06	3.5e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—BRAF—malignant glioma	4.7e-06	3.48e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CD—malignant glioma	4.63e-06	3.43e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—AKT1—malignant glioma	4.62e-06	3.42e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CAV1—malignant glioma	4.59e-06	3.4e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTEN—malignant glioma	4.59e-06	3.4e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TP53—malignant glioma	4.58e-06	3.39e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—AKT2—malignant glioma	4.57e-06	3.38e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—NCOR1—malignant glioma	4.56e-06	3.38e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CB—malignant glioma	4.54e-06	3.36e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.52e-06	3.34e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTGS2—malignant glioma	4.5e-06	3.33e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GSTP1—malignant glioma	4.45e-06	3.3e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—STAT3—malignant glioma	4.41e-06	3.26e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MYC—malignant glioma	4.4e-06	3.25e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CD—malignant glioma	4.39e-06	3.25e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.39e-06	3.25e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GSTP1—malignant glioma	4.35e-06	3.22e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CAT—malignant glioma	4.33e-06	3.21e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—EGFR—malignant glioma	4.3e-06	3.18e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTEN—malignant glioma	4.28e-06	3.17e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTEN—malignant glioma	4.28e-06	3.17e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—KRAS—malignant glioma	4.25e-06	3.14e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CAT—malignant glioma	4.23e-06	3.13e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—FGF2—malignant glioma	4.21e-06	3.11e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CG—malignant glioma	4.18e-06	3.1e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTEN—malignant glioma	4.13e-06	3.06e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.12e-06	3.05e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MYC—malignant glioma	4.1e-06	3.03e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—NCOR1—malignant glioma	4.09e-06	3.03e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—KRAS—malignant glioma	4.06e-06	3.01e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GSTP1—malignant glioma	4.06e-06	3.01e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CB—malignant glioma	4.04e-06	2.99e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PPARG—malignant glioma	4.04e-06	2.99e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—EGFR—malignant glioma	4.01e-06	2.97e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—AKT1—malignant glioma	4.01e-06	2.97e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTGS2—malignant glioma	4e-06	2.96e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—NCOR1—malignant glioma	3.99e-06	2.96e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CAT—malignant glioma	3.95e-06	2.93e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MDM2—malignant glioma	3.94e-06	2.91e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTEN—malignant glioma	3.92e-06	2.9e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—RAF1—malignant glioma	3.92e-06	2.9e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—PIK3CA—malignant glioma	3.9e-06	2.89e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—ERBB2—malignant glioma	3.88e-06	2.87e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—AKT1—malignant glioma	3.86e-06	2.86e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CB—malignant glioma	3.83e-06	2.83e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—KRAS—malignant glioma	3.79e-06	2.8e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TP53—malignant glioma	3.77e-06	2.79e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—NCOR1—malignant glioma	3.73e-06	2.76e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PIK3CA—malignant glioma	3.73e-06	2.76e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PIK3CA—malignant glioma	3.72e-06	2.75e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PIK3CA—malignant glioma	3.72e-06	2.75e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CAV1—malignant glioma	3.72e-06	2.75e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—AKT1—malignant glioma	3.69e-06	2.73e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CD—malignant glioma	3.68e-06	2.72e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TP53—malignant glioma	3.61e-06	2.67e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.55e-06	2.63e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PIK3CA—malignant glioma	3.51e-06	2.6e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTEN—malignant glioma	3.49e-06	2.58e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PIK3CA—malignant glioma	3.48e-06	2.57e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CG—malignant glioma	3.39e-06	2.51e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CAV1—malignant glioma	3.34e-06	2.47e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PTEN—malignant glioma	3.31e-06	2.45e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PPARG—malignant glioma	3.27e-06	2.42e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CAV1—malignant glioma	3.26e-06	2.41e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PIK3CA—malignant glioma	3.24e-06	2.4e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CB—malignant glioma	3.21e-06	2.37e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.19e-06	2.36e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—AKT1—malignant glioma	3.19e-06	2.36e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—AKT1—malignant glioma	3.05e-06	2.26e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CAV1—malignant glioma	3.04e-06	2.25e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CG—malignant glioma	3.04e-06	2.25e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—AKT1—malignant glioma	3.04e-06	2.25e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—AKT1—malignant glioma	3.04e-06	2.25e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CA—malignant glioma	3.02e-06	2.24e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CA—malignant glioma	3.02e-06	2.24e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CD—malignant glioma	2.98e-06	2.2e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CG—malignant glioma	2.97e-06	2.2e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—STAT3—malignant glioma	2.96e-06	2.19e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PPARG—malignant glioma	2.93e-06	2.17e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CA—malignant glioma	2.91e-06	2.16e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.91e-06	2.15e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—AKT1—malignant glioma	2.87e-06	2.13e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PPARG—malignant glioma	2.86e-06	2.12e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—AKT1—malignant glioma	2.84e-06	2.1e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CG—malignant glioma	2.77e-06	2.05e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PTEN—malignant glioma	2.77e-06	2.05e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CA—malignant glioma	2.77e-06	2.05e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MYC—malignant glioma	2.75e-06	2.04e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—EGFR—malignant glioma	2.69e-06	1.99e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PPARG—malignant glioma	2.67e-06	1.98e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CD—malignant glioma	2.67e-06	1.98e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—AKT1—malignant glioma	2.64e-06	1.96e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CD—malignant glioma	2.61e-06	1.93e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CB—malignant glioma	2.59e-06	1.92e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTGS2—malignant glioma	2.57e-06	1.9e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—KRAS—malignant glioma	2.54e-06	1.88e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—AKT1—malignant glioma	2.47e-06	1.83e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—AKT1—malignant glioma	2.47e-06	1.83e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CA—malignant glioma	2.46e-06	1.82e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CD—malignant glioma	2.44e-06	1.8e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—AKT1—malignant glioma	2.38e-06	1.76e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CA—malignant glioma	2.33e-06	1.73e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CB—malignant glioma	2.33e-06	1.72e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTGS2—malignant glioma	2.31e-06	1.71e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CB—malignant glioma	2.27e-06	1.68e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—AKT1—malignant glioma	2.26e-06	1.67e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTGS2—malignant glioma	2.25e-06	1.67e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTEN—malignant glioma	2.24e-06	1.66e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CB—malignant glioma	2.12e-06	1.57e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTGS2—malignant glioma	2.1e-06	1.56e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTEN—malignant glioma	2.01e-06	1.49e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—AKT1—malignant glioma	2.01e-06	1.49e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTEN—malignant glioma	1.96e-06	1.45e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CA—malignant glioma	1.95e-06	1.45e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—AKT1—malignant glioma	1.91e-06	1.41e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTEN—malignant glioma	1.83e-06	1.36e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—AKT1—malignant glioma	1.6e-06	1.18e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CA—malignant glioma	1.58e-06	1.17e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CA—malignant glioma	1.42e-06	1.05e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CA—malignant glioma	1.39e-06	1.03e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.29e-06	9.58e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AKT1—malignant glioma	1.29e-06	9.56e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AKT1—malignant glioma	1.16e-06	8.59e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AKT1—malignant glioma	1.13e-06	8.38e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AKT1—malignant glioma	1.06e-06	7.83e-06	CbGpPWpGaD
